Revue Neurologique

Papers
(The H4-Index of Revue Neurologique is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians152
Epidemiology of neurological diseases in older adults60
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects51
CGRP and migraine: from bench to bedside48
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention43
Neurofeedback for cognitive enhancement and intervention and brain plasticity36
Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection30
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment29
Pregnancy with multiple sclerosis28
French guidelines for neuropathic pain: An update and commentary27
Migraine with aura26
Syringomyelia and hydromyelia: Current understanding and neurosurgical management26
Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)25
Clinical and genetic update of hereditary spastic paraparesis24
Therapeutic news in ALS24
Lafora disease: Current biology and therapeutic approaches21
Intensive care unit-acquired weakness: Questions the clinician should ask21
FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS20
From competition to cooperation: Visual neglect across the hemispheres20
Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment19
Spinal cord stimulation for neuropathic pain19
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis19
Brain plasticity and hearing disorders19
0.091539144515991